Oryzon Genomics S.A. (ORY.MC)

EUR 2.66

(1.33%)

Total Assets Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual total assets in 2023 was 106.9 Million EUR , up 3.09% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly total assets in 2024 Q3 was 122.66 Million EUR , up 10.83% from previous quarter.
  • Oryzon Genomics S.A. reported annual total assets of 103.69 Million EUR in 2022, up 8.72% from previous year.
  • Oryzon Genomics S.A. reported annual total assets of 95.38 Million EUR in 2021, up 1.36% from previous year.
  • Oryzon Genomics S.A. reported quarterly total assets of 122.66 Million EUR for 2024 Q3, up 10.83% from previous quarter.
  • Oryzon Genomics S.A. reported quarterly total assets of 110.67 Million EUR for 2024 Q2, up 10.34% from previous quarter.

Annual Total Assets Chart of Oryzon Genomics S.A. (2023 - 2019)

Created with Highcharts 11.1.0YearsTotal Assets20192019.520202020.520212021.520222022.520230 EUR25000000 EUR50000000 EUR75000000 EUR100000000 EUR125000000 EUR

Historical Annual Total Assets of Oryzon Genomics S.A. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 106.9 Million EUR 3.09%
2022 103.69 Million EUR 8.72%
2021 95.38 Million EUR 1.36%
2020 94.1 Million EUR 0.0%
2019 - EUR 0.0%

Peer Total Assets Comparison of Oryzon Genomics S.A.

Name Total Assets Total Assets Difference
Atrys Health, S.A. 629 Million EUR 83.005%
Biotechnologies Assets SA 16.6 Million EUR -543.692%
Pharma Mar, S.A. 341.22 Million EUR 68.671%
Laboratorios Farmaceuticos Rovi, S.A. 799.88 Million EUR 86.636%